Hemodynamic Optimization of Cerebral Perfusion After Endovascular Therapy in Patients With Acute Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 814 participants.
Also called NCT04892511
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 814 participants
- Registry
-
NCT04892511
-
- Other papers using this trial's data
- Personalized Blood Pressure Targeting After Endovascular Therapy for Acute Ischemic Stroke: A Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Spain
- Registry status
- Unknown status
Technical summary
Registry record NCT04892511. Randomized; no masking; primary purpose treatment. Start 2021-06-01 (actual); primary completion 2024-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Hemodynamic Optimization of Cerebral Perfusion After Endovascular Therapy in Patients With Acute Ischemic Stroke
- Acronym
- HOPE
- Condition
- Acute Ischemic Stroke
- Intervention (Other)
- Adjusted medication
- Lead sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Record details
- Record id
cardio:ct-nct04892511- Content hash
dcd0cda423879bcb9b5355f0f78e68a012da011550fc096dc508d2a8571852a4